Archives of Clinical Infectious Diseases

Published by: Kowsar

Reports of Vancomycin-Resistant Staphylococcus aureus from Middle East Countries

Fereshteh Rahimipour 1 , Kiarash Ghazvini 2 and Masoud Youssefi 2 , *
Authors Information
1 Department of Molecular and Cell Biology, Faculty of Basic Science, University of Mazandaran, Babolsar, Iran
2 Antimicrobial Resistance Research Center, Bu Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Article information
  • Archives of Clinical Infectious Diseases: April 2018, 13 (2); e59522
  • Published Online: March 11, 2018
  • Article Type: Review Article
  • Received: July 17, 2016
  • Revised: August 6, 2017
  • Accepted: September 19, 2017
  • DOI: 10.5812/archcid.59522

To Cite: Rahimipour F, Ghazvini K, Youssefi M. Reports of Vancomycin-Resistant Staphylococcus aureus from Middle East Countries, Arch Clin Infect Dis. 2018 ; 13(2):e59522. doi: 10.5812/archcid.59522.

Abstract
Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Context
2. Methods
3. Results
4. Discussion
Footnote
References
  • 1. Harris LG, Foster SJ, Richards RG. An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. Eur Cell Mater. 2002;4:39-60. doi: 10.22203/eCM.v004a04. [PubMed: 14562246].
  • 2. Tarai B, Das P, Kumar D. Recurrent Challenges for Clinicians: Emergence of Methicillin-Resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options. J Lab Physicians. 2013;5(2):71-8. doi: 10.4103/0974-2727.119843. [PubMed: 24701097].
  • 3. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010;23(1):99-139. doi: 10.1128/CMR.00042-09. [PubMed: 20065327].
  • 4. Yaseen IH, Shareef AY, Daoud AS. High prevalence of multidrug-resistance MRSA and VRSA of different infections from Al-Jumhuory Teaching Hospital patients in Mosul. J Life Sci. 2013;7(12).
  • 5. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 2001;1(3):147-55. doi: 10.1016/S1473-3099(01)00091-3. [PubMed: 11871491].
  • 6. El-Baky R. Prevalence and conjugal transfer of vancomycin resistance among clinical isolates of Staphylococcus aureus. Adv Res. 2014;2(1):12-23. doi: 10.9734/air/2014/7142.
  • 7. Moravvej Z, Estaji F, Askari E, Solhjou K, Naderi Nasab M, Saadat S. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains. Int J Antimicrob Agents. 2013;42(4):370-1. doi: 10.1016/j.ijantimicag.2013.06.004. [PubMed: 23880172].
  • 8. Perichon B, Courvalin P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53(11):4580-7. doi: 10.1128/AAC.00346-09. [PubMed: 19506057].
  • 9. Holmes NE, Johnson PD, Howden BP. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections. J Clin Microbiol. 2012;50(8):2548-52. doi: 10.1128/JCM.00775-12. [PubMed: 22593595].
  • 10. Saderi H, Owlia P, Shahrbanooie R. Vancomycin resistance among clinical isolates of Staphylococcus aureus. Arch Iranian Med. 2005;8(2):100-3.
  • 11. Bataineh HA. Resistance of staphyiococcus aureus to vancomycin in Zarqa, Jordan. Pak J Med Sci. 2006;22(2):144-8.
  • 12. Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract. 2008;17(5):432-4. doi: 10.1159/000141513. [PubMed: 18685289].
  • 13. Saderi H, Owlia P, Maleki Z, Habibi M, Rahmati N. Susceptibility to vancomycin in Staphylococcus aureus isolated from patients of four university-affiliated hospitals in Tehran. Iranian Journal of Pathology. 2008;3(3):161-7.
  • 14. Medhat A, Mesbah MR, El-Naggar MM, Khalil ESA, El-Kenawy MF. The first two vancomycin resistant Staphylococcus aureus isolates in Mansoura University hospital; epidemiology and antimicrobial study. Egypt J Med Microbiol. 2008;17(1):31-43.
  • 15. Ghasemian R, Najafi N, Makhlough A, Khademloo M. Frequency of nasal carriage of Staphylococcus aureus and its antimicrobial resistance pattern in patients on hemodialysis. Iran J Kidney Dis. 2010;4(3):218-22. [PubMed: 20622310].
  • 16. Taj Y, Abdullah FE, Kazmi SU. Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance. J Coll Physicians Surg Pak. 2010;20(11):728-32. [PubMed: 21078245].
  • 17. Hosain Z. The prevalence of methicillin and vancomycin resistant Staphylococcus aureus nasal carriage in large teaching hospital personnel. Afr J Microbiol Res. 2011;5(22):3716-9. doi: 10.5897/ajmr11.518.
  • 18. Rebiahi SA, Abdelouahid DE, Rahmoun M, Abdelali S, Azzaoui H. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria). Med Mal Infect. 2011;41(12):646-51. doi: 10.1016/j.medmal.2011.09.010. [PubMed: 22033230].
  • 19. Mirani ZA, Jamil N. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus. J Basic Microbiol. 2011;51(2):191-5. doi: 10.1002/jobm.201000221. [PubMed: 20967790].
  • 20. Dezfulian A, Aslani MM, Oskoui M, Farrokh P, Azimirad M, Dabiri H, et al. Identification and Characterization of a High Vancomycin-Resistant Staphylococcus aureus Harboring VanA Gene Cluster Isolated from Diabetic Foot Ulcer. Iran J Basic Med Sci. 2012;15(2):803-6. [PubMed: 23495359].
  • 21. Azimian A, Havaei SA, Fazeli H, Naderi M, Ghazvini K, Samiee SM, et al. Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran. J Clin Microbiol. 2012;50(11):3581-5. doi: 10.1128/JCM.01727-12. [PubMed: 22933598].
  • 22. Abu Shady H, El-Essawy A, Salama M, El-Ayesh A. Detection and molecular characterization of vancomycin resistant Staphylococcus aureus from clinical isolates. Afr J Biotech. 2012;11(99):16494-503.
  • 23. Alzolibani AA, Al Robaee AA, Al Shobaili HA, Bilal JA, Issa Ahmad M, Bin Saif G. Documentation of vancomycin-resistant Staphylococcus aureus (VRSA) among children with atopic dermatitis in the Qassim region, Saudi Arabia. Acta Dermatovenerol Alp Pannonica Adriat. 2012;21(3):51-3. doi: 10.2478/v10162-012-0015-2. [PubMed: 23267872].
  • 24. Armin S, Rouhipour A, Fallah F, Rahbar M, Ebrahimi M. Vancomycin and linezolid resistant staphylococcus in hospitalized children. Arch Pediatr Infect Dis. 2012;1(1):4-8. doi: 10.5812/pedinfect.5190.
  • 25. Abou Shady HM, Bakr AE, Hashad ME, Alzohairy MA. Staphylococcus aureus nasal carriage among outpatients attending primary health care centers: a comparative study of two cities in Saudi Arabia and Egypt. Braz J Infect Dis. 2015;19(1):68-76. doi: 10.1016/j.bjid.2014.09.005. [PubMed: 25523075].
  • 26. Mohaghegh MA, Ghazvini K, Jafari R, Alikhani MY, Safari M, Azari Garamjan GA, et al. Retrospective study on the prevalence and antibiotic resistance pattern of Staphylococcus aureus and staphylococcus epidermidis among patients suspicious of bacteremia during 2006 - 2011. Int J Enteric Pathogens. 2015;3(2). doi: 10.17795/ijep22930.
  • 27. Naghavi-Behzad M, Akhi MT, Alizadeh M, Saleh P, Jafarzadeh S, Sohrab-Navi Z. Staphylococcus aureus: resistance pattern and risk factors. , J Anal Res Clin Med. 2015;3(1):43-50. doi: 10.15171/jarcm.2015.007.
  • 28. Liaqat F, Sheikh AA, Nazir J, Hussain T, Rabbani M, Shaheen AY, et al. Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus. Pak J Pharm Sci. 2015;28(3):997-1004. [PubMed: 26004734].
  • 29. El-Banna TES, Sonbol FI, El-Aziz AAA, El-Ekhnawy EAS. Characterization of vancomycin resistant Staphylococcus aureus in Tanta University hospital. Int J Curr Microbiol App Sci. 2015;4(10):1-11.
  • 30. Arianpoor A, Estaji F, Naderinasab M, Askari E. Antimicrobial susceptibility pattern of Staphylococcus aureus isolates against newly marketed antibiotics: A report from Imam Reza Hospital of Mashhad, Iran. Razavi Int J Med. 2015;3(4). doi: 10.17795/rijm31568.
  • 31. Yadegarynia D, Taheri M, Arabmazar Z, Darvishi A. Evaluation of Antimicrobial Susceptibility among Staphylococcus aureus by E-test Method at Khatam-Ol-Anbia Hospital during 2013-2015 [In Persian]. Q J Sch Med. 2016;40(1):24-9.
  • 32. Sarrafzadeh F, Mirzabiegi Z, Torabi-Nami M, Schumacher U. Vancomycin-Resistant Staphylococcus aureus isolates among hospitalized patients; a tertiary medical care center experience from Southern Iran. Cogent Med. 2016;3(1). doi: 10.1080/2331205x.2016.1163768.
  • 33. Karimzadeh I, Mirzaee M, Sadeghimanesh N, Sagheb MM. Antimicrobial resistance pattern of Gram-positive bacteria during three consecutive years at the nephrology ward of a tertiary referral hospital in Shiraz, Southwest Iran. J Res Pharm Pract. 2016;5(4):238-47. doi: 10.4103/2279-042X.192460. [PubMed: 27843959].
  • 34. Hiramatsu K, Kayayama Y, Matsuo M, Aiba Y, Saito M, Hishinuma T, et al. Vancomycin-intermediate resistance in Staphylococcus aureus. J Glob Antimicrob Resist. 2014;2(4):213-24. doi: 10.1016/j.jgar.2014.04.006. [PubMed: 27873679].
  • 35. Appelbaum PC. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2006;12 Suppl 1:16-23. doi: 10.1111/j.1469-0691.2006.01344.x. [PubMed: 16445720].
  • 36. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13(4):686-707. doi: 10.1128/CMR.13.4.686-707.2000. [PubMed: 11023964].
  • 37. Bartley J. First case of VRSA identified in Michigan. Infect Control Hosp Epidemiol. 2002;23(8):480. doi: 10.1017/S0195941700082333. [PubMed: 12186219].
  • 38. Thati V, Shivannavar CT, Gaddad SM. Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res. 2011;134(5):704-8. doi: 10.4103/0971-5916.91001. [PubMed: 22199111].
  • 39. Tiwari KB. Vancomycin resistance in Staphylococcus aureus may occur faster than expected. Int J Life Sci. 2009;3(0). doi: 10.3126/ijls.v3i0.2302.
  • 40. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057-98. doi: 10.1016/S1473-3099(13)70318-9. [PubMed: 24252483].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments